T.MAN Pharmaceutical PCL (BKK:TMAN) Other Current Liabilities: ฿9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
21 GF Score
Price ฿10.70
View Full Analysis

What is T.MAN Pharmaceutical PCL Other Current Liabilities?

T.MAN Pharmaceutical PCL BKK:TMAN -0.93% 21 Other Current Liabilities is ฿9 Mil as of Jun. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100.

T.MAN Pharmaceutical PCL's other current liabilities for the quarter that ended in Jun. 2026 was ฿9 Mil.

T.MAN Pharmaceutical PCL's quarterly other current liabilities declined from Dec. 2025 (฿10 Mil) to Mar. 2026 (฿10 Mil) and declined from Mar. 2026 (฿10 Mil) to Jun. 2026 (฿9 Mil).

T.MAN Pharmaceutical PCL's annual other current liabilities declined from Dec. 2023 (฿24 Mil) to Dec. 2024 (฿10 Mil) and declined from Dec. 2024 (฿10 Mil) to Dec. 2025 (฿10 Mil).

T.MAN Pharmaceutical PCL Other Current Liabilities Related Terms

T.MAN Pharmaceutical PCL Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Other Current Liabilities Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
20.46 23.98 10.27 10.09

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.43 11.05 10.09 9.54 8.93
BKK:TMAN
21GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ฿9 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Other Current Liabilities of ฿9 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on T.MAN Pharmaceutical PCL.
Is T.MAN Pharmaceutical PCL's Other Current Liabilities too high?
T.MAN Pharmaceutical PCL's current Other Current Liabilities is ฿9 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Other Current Liabilities compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Other Current Liabilities of ฿9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on T.MAN Pharmaceutical PCL. T.MAN Pharmaceutical PCL's current Other Current Liabilities is ฿9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Other Current Liabilities of ฿9 Mil. The current Other Current Liabilities is ฿9 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Other Current Liabilities is ฿9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score

Get the complete analysis for BKK:TMAN

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿10.70
Price